Zobrazeno 1 - 4
of 4
pro vyhledávání: '"AI Idoate Grijalba"'
Autor:
M de Pablo Fernández, LM Fernández Azcona, B Fernandez Garcia, C Fraile Rodriguez, AI Idoate Grijalba, A. Idoate García
Publikováno v:
Eur J Hosp Pharm
Background Implantable medical devices (IDs) management in the hospital is a complex process, with a large scope for improvement that satisfies technical, logistical, economic and clinical needs. Purpose Integrate into a single process all the activi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00e9c8d6cf328b0524938b8bae5ee049
https://doi.org/10.1136/ejhpharm-2018-eahpconf.37
https://doi.org/10.1136/ejhpharm-2018-eahpconf.37
Autor:
AI Idoate Grijalba, M.Á. García Del Barrio, E. Castanon Alvarez, I. Gil Bazo, B Sangro Gómez-Acebo
Publikováno v:
Eur J Hosp Pharm
Background ALK-inhibitors are indicated in adult patients with ALK-positive advanced NSCLC, with crizotinib being the first choice. Hepatotoxicity has been described for crizotinib and ceritinib. Purpose To describe a case of alectinib hepatic-tolera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a23077f2406868cc47bbea8b84d28117
https://doi.org/10.1136/ejhpharm-2018-eahpconf.207
https://doi.org/10.1136/ejhpharm-2018-eahpconf.207
Autor:
Aldaz A; Clínica Universidad de Navarra, Pharmacy Services; and., Idoate Grijalba AI; Clínica Universidad de Navarra, Pharmacy Services; and., Ortega A; Clínica Universidad de Navarra, Pharmacy Services; and., Aquerreta I; Clínica Universidad de Navarra, Pharmacy Services; and., Monedero P; Clínica Universidad de Navarra, Anaesthesia and Intensive Care Department, Pamplona, Spain.
Publikováno v:
Therapeutic drug monitoring [Ther Drug Monit] 2021 Apr 01; Vol. 43 (2), pp. 256-263.
Autor:
Idoate Grijalba AI; Pharmacy department, Clinica Universidad de Navarra, 31008, Pamplona, Spain. anaisabelidoate@gmail.com., Aldaz Pastor A; Pharmacy department, Clinica Universidad de Navarra, 31008, Pamplona, Spain., Marquet P; IPPRITT, Univ. Limoges, F-87000, Limoges, France.; IPPRITT, INSERM, U1248, F-87000, Limoges, France.; CHU Limoges, F-87000, Limoges, France., Woillard JB; IPPRITT, Univ. Limoges, F-87000, Limoges, France.; IPPRITT, INSERM, U1248, F-87000, Limoges, France.; CHU Limoges, F-87000, Limoges, France.
Publikováno v:
European journal of clinical pharmacology [Eur J Clin Pharmacol] 2019 Oct; Vol. 75 (10), pp. 1405-1414. Date of Electronic Publication: 2019 Jul 23.